|
Equity (Details 1) (USD $)
|
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2014
|
Mar. 31, 2013
|
|
| Gross Proceeds From Issuance Initial Public Offering | $ 14,998,500 | |
| Payments of Stock Issuance Costs | 1,897,164 | |
| Proceeds from Issuance Initial Public Offering | 13,101,336 | 0 |
|
Legal Accounting Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 393,298 | |
|
Printing Document Prep [Member]
|
||
| Payments of Stock Issuance Costs | 62,101 | |
|
Registration Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 55,946 | |
|
Road Show Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 41,764 | |
|
Underwriter Commission [Member]
|
||
| Payments of Stock Issuance Costs | 1,049,895 | |
|
Underwriter Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 149,985 | |
|
Aegis Legal Fees [Member]
|
||
| Payments of Stock Issuance Costs | 80,000 | |
|
Aegis Registration Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 7,500 | |
|
Aegis Miscellaneous Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 36,675 | |
|
Aegis Road Show Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 20,000 | |
|
Underwriter And Aegis Expenses [Member]
|
||
| Payments of Stock Issuance Costs | 1,344,055 | |
|
Akers Biosciences Expenses [Member]
|
||
| Payments of Stock Issuance Costs | $ 553,109 | |